These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2260 related articles for article (PubMed ID: 11056663)
21. Efficacy of daily compared to intermittent administration of IL-1Ra for protection against bone and cartilage destruction in collagen-challenged mice. Inoue K; Masuko-Hongo K; Okamoto M; Nishioka K Clin Exp Rheumatol; 2003; 21(1):33-9. PubMed ID: 12673887 [TBL] [Abstract][Full Text] [Related]
22. The suppressive effects of Saposhnikovia divaricata (Fangfeng) chromone extract on rheumatoid arthritis via inhibition of nuclear factor-κB and mitogen activated proteinkinases activation on collagen-induced arthritis model. Kong X; Liu C; Zhang C; Zhao J; Wang J; Wan H; Zhu H; Zhang P; Chen W; Xiao Y; Lin N J Ethnopharmacol; 2013 Jul; 148(3):842-50. PubMed ID: 23711830 [TBL] [Abstract][Full Text] [Related]
23. Dual role of IL-12 in early and late stages of murine collagen type II arthritis. Joosten LA; Lubberts E; Helsen MM; van den Berg WB J Immunol; 1997 Oct; 159(8):4094-102. PubMed ID: 9379000 [TBL] [Abstract][Full Text] [Related]
24. Adrenomedullin(22-52) combats inflammation and prevents systemic bone loss in murine collagen-induced arthritis. Ah Kioon MD; Asensio C; Ea HK; Velard F; Uzan B; Rullé S; Bazille C; Marty C; Falgarone G; Nguyen C; Collet C; Launay JM; Cohen-Solal M; Lioté F Arthritis Rheum; 2012 Apr; 64(4):1069-81. PubMed ID: 22006509 [TBL] [Abstract][Full Text] [Related]
25. A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis. Saito H; Kojima T; Takahashi M; Horne WC; Baron R; Amagasa T; Ohya K; Aoki K Arthritis Rheum; 2007 Apr; 56(4):1164-74. PubMed ID: 17393436 [TBL] [Abstract][Full Text] [Related]
26. A selective p38 alpha mitogen-activated protein kinase inhibitor reverses cartilage and bone destruction in mice with collagen-induced arthritis. Medicherla S; Ma JY; Mangadu R; Jiang Y; Zhao JJ; Almirez R; Kerr I; Stebbins EG; O'Young G; Kapoun AM; Luedtke G; Chakravarty S; Dugar S; Genant HK; Protter AA J Pharmacol Exp Ther; 2006 Jul; 318(1):132-41. PubMed ID: 16597712 [TBL] [Abstract][Full Text] [Related]
27. Blocking of CD27-CD70 pathway by anti-CD70 antibody ameliorates joint disease in murine collagen-induced arthritis. Oflazoglu E; Boursalian TE; Zeng W; Edwards AC; Duniho S; McEarchern JA; Law CL; Gerber HP; Grewal IS J Immunol; 2009 Sep; 183(6):3770-7. PubMed ID: 19710474 [TBL] [Abstract][Full Text] [Related]
28. Treatment with anti-gamma-glutamyl transpeptidase antibody attenuates osteolysis in collagen-induced arthritis mice. Ishizuka Y; Moriwaki S; Kawahara-Hanaoka M; Uemura Y; Serizawa I; Miyauchi M; Shibata S; Kanaya T; Takata T; Taniguchi N; Niida S J Bone Miner Res; 2007 Dec; 22(12):1933-42. PubMed ID: 17680722 [TBL] [Abstract][Full Text] [Related]
29. Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis. Bendele AM; Chlipala ES; Scherrer J; Frazier J; Sennello G; Rich WJ; Edwards CK Arthritis Rheum; 2000 Dec; 43(12):2648-59. PubMed ID: 11145022 [TBL] [Abstract][Full Text] [Related]
30. META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis. Konda VR; Desai A; Darland G; Bland JS; Tripp ML Arthritis Rheum; 2010 Jun; 62(6):1683-92. PubMed ID: 20201075 [TBL] [Abstract][Full Text] [Related]
31. Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis. Bai F; Tian H; Niu Z; Liu M; Ren G; Yu Y; Sun T; Li S; Li D Int J Mol Med; 2014 Mar; 33(3):711-21. PubMed ID: 24378614 [TBL] [Abstract][Full Text] [Related]
32. Electrotransfer of human IL-1Ra into skeletal muscles reduces the incidence of murine collagen-induced arthritis. Jeong JG; Kim JM; Ho SH; Hahn W; Yu SS; Kim S J Gene Med; 2004 Oct; 6(10):1125-33. PubMed ID: 15452879 [TBL] [Abstract][Full Text] [Related]
33. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra. Joosten LA; Helsen MM; van de Loo FA; van den Berg WB Arthritis Rheum; 1996 May; 39(5):797-809. PubMed ID: 8639177 [TBL] [Abstract][Full Text] [Related]
34. Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts. Neidhart M; Gay RE; Gay S Arthritis Rheum; 2000 Aug; 43(8):1719-28. PubMed ID: 10943861 [TBL] [Abstract][Full Text] [Related]
35. Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis. Nozaki Y; Yamagata T; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M Clin Immunol; 2006 Jun; 119(3):272-9. PubMed ID: 16412693 [TBL] [Abstract][Full Text] [Related]
36. Oleanolic acid acetate inhibits rheumatoid arthritis by modulating T cell immune responses and matrix-degrading enzymes. Choi JK; Kim SW; Kim DS; Lee JY; Lee S; Oh HM; Ha YS; Yoo J; Park PH; Shin TY; Kwon TK; Rho MC; Kim SH Toxicol Appl Pharmacol; 2016 Jan; 290():1-9. PubMed ID: 26570984 [TBL] [Abstract][Full Text] [Related]
37. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T cell activation. Magari K; Miyata S; Ohkubo Y; Mutoh S Inflamm Res; 2004 Sep; 53(9):469-74. PubMed ID: 15551000 [TBL] [Abstract][Full Text] [Related]
38. Oleuropein aglycone, an olive oil compound, ameliorates development of arthritis caused by injection of collagen type II in mice. Impellizzeri D; Esposito E; Mazzon E; Paterniti I; Di Paola R; Morittu VM; Procopio A; Britti D; Cuzzocrea S J Pharmacol Exp Ther; 2011 Dec; 339(3):859-69. PubMed ID: 21880869 [TBL] [Abstract][Full Text] [Related]
39. Increased expression of interleukin-22 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation. Marijnissen RJ; Koenders MI; Smeets RL; Stappers MH; Nickerson-Nutter C; Joosten LA; Boots AM; van den Berg WB Arthritis Rheum; 2011 Oct; 63(10):2939-48. PubMed ID: 21618207 [TBL] [Abstract][Full Text] [Related]
40. CGS 21680, an agonist of the adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis. Mazzon E; Esposito E; Impellizzeri D; DI Paola R; Melani A; Bramanti P; Pedata F; Cuzzocrea S J Rheumatol; 2011 Oct; 38(10):2119-29. PubMed ID: 21765105 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]